Alerts will be sent to your verified email
Verify Email
BROOKS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Brooks Laboratories Limited focuses on critical care products including Beta Lactam, Cephalosporin, and General Dry powder Injectables. It provides a diverse product portfolio for multiple companies.
Brooks Laboratories major competitors are Panchsheel Organics, Kimia Biosciences, Vaidya Sane Ayur Lab, Coral Laboratories, Lyka Labs, Alpa Lab, Krebs Biochem.&Inds.
Market Cap of Brooks Laboratories is ₹184 Crs.
While the median market cap of its peers are ₹172 Crs.
Brooks Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Brooks Laboratories is 5.87 and is ranked 4 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Dec | ||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Claude
|
